Literature DB >> 7607499

On the insertion of foreign DNA into mammalian genomes: mechanism and consequences.

W Doerfler1, G Orend, R Schubbert, K Fechteler, H Heller, P Wilgenbus, J Schröer.   

Abstract

We have studied the integration of adenovirus type 12 (Ad12) DNA in transformed and hamster tumor cells over many years. Upon infection of hamster cells with Ad12, viral DNA has been found in association with hamster chromosomes, possibly in part integrated into the host genome. Ad12 DNA integration is not sequence specific. Transcriptionally active sites of the host genome show a preponderance for foreign DNA insertion. We are pursuing the mechanism of Ad12 DNA integrative recombination in a cell-free system prepared from hamster cell nuclear extracts. In a number of Ad12-transformed hamster cell lines or in cell lines carrying foreign DNA, we have located the inserted Ad12 DNA copies on hamster chromosomes by fluorescent in situ hybridization (FISH). Among the consequences of Ad12 DNA integration, we have studied the de novo methylation of the integrated foreign (Ad12) DNA and increases in DNA methylation in several cellular genes and DNA segments in Ad12-transformed and hamster tumor cells. Several lines of evidence argue for the notion that parameters in addition to nucleotide sequence, in particular site of integration and/or the chromatin configuration of the integrated DNA, are important in generating de novo methylation patterns. The de novo methylation of integrated foreign DNA can be interpreted as an old cellular defense mechanism against the activity of foreign genes in an established genome. Pursuing this concept, we have asked for the most likely portal of entry of foreign DNA, supposedly the gastrointestinal tract in most animals. This hypothesis has been tested by feeding mice linearized or circular, double-stranded bacteriophage M13mp18 DNA.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7607499     DOI: 10.1016/0378-1119(95)00080-p

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  4 in total

Review 1.  Self-DNA inhibitory effects: Underlying mechanisms and ecological implications.

Authors:  Fabrizio Cartenì; Giuliano Bonanomi; Francesco Giannino; Guido Incerti; Christian Ernest Vincenot; Maria Luisa Chiusano; Stefano Mazzoleni
Journal:  Plant Signal Behav       Date:  2016

2.  Results of multicenter double-blind placebo-controlled phase II clinical trial of Panagen preparation to evaluate its leukostimulatory activity and formation of the adaptive immune response in patients with stage II-IV breast cancer.

Authors:  Anastasia S Proskurina; Tatiana S Gvozdeva; Ekaterina A Alyamkina; Evgenia V Dolgova; Konstantin E Orishchenko; Valeriy P Nikolin; Nelly A Popova; Sergey V Sidorov; Elena R Chernykh; Alexandr A Ostanin; Olga Y Leplina; Victoria V Dvornichenko; Dmitriy M Ponomarenko; Galina S Soldatova; Nikolay A Varaksin; Tatiana G Ryabicheva; Peter N Uchakin; Stanislav N Zagrebelniy; Vladimir A Rogachev; Sergey S Bogachev; Mikhail A Shurdov
Journal:  BMC Cancer       Date:  2015-03-13       Impact factor: 4.430

3.  Five-year disease-free survival among stage II-IV breast cancer patients receiving FAC and AC chemotherapy in phase II clinical trials of Panagen.

Authors:  Anastasia S Proskurina; Tatiana S Gvozdeva; Ekaterina A Potter; Evgenia V Dolgova; Konstantin E Orishchenko; Valeriy P Nikolin; Nelly A Popova; Sergey V Sidorov; Elena R Chernykh; Alexandr A Ostanin; Olga Y Leplina; Victoria V Dvornichenko; Dmitriy M Ponomarenko; Galina S Soldatova; Nikolay A Varaksin; Tatiana G Ryabicheva; Peter N Uchakin; Vladimir A Rogachev; Mikhail A Shurdov; Sergey S Bogachev
Journal:  BMC Cancer       Date:  2016-08-18       Impact factor: 4.430

4.  Analysis of bacteria from intestinal tract of FAP patients for the presence of APC-like sequences.

Authors:  Vladimir Holec; Sona Ciernikova; Lenka Wachsmannova; Zuzana Adamcikova; Katarina Hainova; Michal Mego; Viola Stevurkova; Ludovit Danihel; Anna Liskova; Vladimir Zajac
Journal:  Med Sci Monit       Date:  2012-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.